SLCO1B1 and glycogen storage disease VI: While, to date, according to The University of WashingtonDrug Interaction Database (DIDB),38 nocentral nervous system agents have been identified as OATP1B1 substrates,many other drugs can be prescribed to these patients to treat theirsomatic diseases.